Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2016, Article ID 1656182, 3 pages
http://dx.doi.org/10.1155/2016/1656182
Case Report

Severe Ketoacidosis Associated with Canagliflozin (Invokana): A Safety Concern

1Section of Pulmonary and Critical Care Medicine, Providence Hospital and Medical Center, 16001 W 9 Mile Road, Southfield, MI 48075, USA
2Department of Internal Medicine, Providence Hospital and Medical Center, 16001 W 9 Mile Road, Southfield, MI 48075, USA

Received 19 January 2016; Accepted 9 March 2016

Academic Editor: Kurt Lenz

Copyright © 2016 Alehegn Gelaye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Jessica Turner, Tahmina Begum, and Roger D Smalligan, “Canagliflozin-Induced Diabetic Ketoacidosis: Case Report and Review of the Literature.,” Journal of investigative medicine high impact case reports, vol. 4, no. 3, pp. 2324709616663231, . View at Publisher · View at Google Scholar
  • Nellowe Candelario, and Jedrzej Wykretowicz, “The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.,” Oxford medical case reports, vol. 2016, no. 7, pp. 144–6, 2016. View at Publisher · View at Google Scholar
  • Ronald M. Goldenberg, Lori D. Berard, Alice Y.Y. Cheng, Jeremy D. Gilbert, Subodh Verma, Vincent C. Woo, and Jean-François Yale, “SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis,” Clinical Therapeutics, vol. 38, no. 12, pp. 2654–2664.e1, 2016. View at Publisher · View at Google Scholar
  • Asma Abu-Abed Abdin, Muhammad Hamza, Muhammad S. Khan, and Awab Ahmed, “Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication,” Case Reports in Critical Care, vol. 2016, pp. 1–4, 2016. View at Publisher · View at Google Scholar
  • Prashanth Rawla, Anantha R Vellipuram, Sathyajit S Bandaru, and Jeffrey Pradeep Raj, “Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma,” Endocrinology, Diabetes & Metabolism Case Reports, 2017. View at Publisher · View at Google Scholar
  • Sayf A Yassin, and Vanita R Aroda, “Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale.,” Drug design, development and therapy, vol. 11, pp. 923–937, 2017. View at Publisher · View at Google Scholar
  • D. A. Milder, T. Y. Milder, and P. C. A. Kam, “Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations,” Anaesthesia, 2018. View at Publisher · View at Google Scholar
  • Pablo Lucero, and Sebastián Chapela, “Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature,” Case Reports in Critical Care, vol. 2018, pp. 1–6, 2018. View at Publisher · View at Google Scholar